The role of different P-glycoproteins in hepatobiliary secretion of fluorescently labeled short-chain phospholipids

J Lipid Res. 1999 Nov;40(11):1950-8.

Abstract

Class III P-glycoproteins (Pgps) mediate biliary phosphatidylcholine (PC) secretion. Recent findings that class I P-glycoproteins are able to transport several short-chain phospholipid analogues raises questions about the role of these Pgps in physiological lipid transport. We investigated the biliary secretion of C6-7-nitro-2,1, 3-benzoxadiazol-4-yl (NBD)-labeled ceramide and its metabolites in Mdr1a/b and Mdr2 knockout mice compared to control mice. Biliary secretion of these NBD-lipids was unaffected in Mdr1a/b -/- mice. Thus neither Mdr1a nor Mdr1b Pgp mediates biliary secretion of these lipids. In contrast, secretion of all three NBD-labeled short-chain phospholipids was significantly reduced in Mdr2 -/- mice. As in vitro studies revealed that Mdr2 Pgp is not able to translocate these lipid analogues, we hypothesized that Mdr2 -/- mice had a reduced PC content of the exoplasmic canalicular membrane leaflet so that extraction of the short-chain lipid probes from this membrane by canalicular bile salts was impaired. To investigate this possibility we studied the bile salt-mediated extraction of natural sphingomyelin (SM) and NBD-labeled short-chain SM from small unilamellar vesicles of different lipid composition. Natural SM could be extracted by the bile salt tauroursodeoxycholate from vesicles containing PC, cholesterol (CHOL), and SM (1:2:2) but not from vesicles containing only SM and CHOL (3:2). NBD-labeled short-chain SM could be extracted from vesicles containing PC while its extraction from pure SM:CHOL vesicles was reduced by 65%. These data confirm that the efficiency of NBD-SM extraction depends on the lipid composition and suggest that the canalicular membrane outer leaflet of Mdr2 -/- mice has a reduced PC content.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Chloro-7-nitrobenzofurazan / analogs & derivatives
  • 4-Chloro-7-nitrobenzofurazan / analysis
  • 4-Chloro-7-nitrobenzofurazan / metabolism
  • ATP Binding Cassette Transporter, Subfamily B / pharmacology*
  • Albumins / metabolism
  • Animals
  • Bile / chemistry
  • Bile / drug effects
  • Bile Canaliculi / metabolism
  • Biliary Tract / drug effects
  • Biliary Tract / metabolism*
  • Carrier Proteins
  • Ceramides / metabolism
  • Fluorescent Dyes
  • Genes, MDR
  • Liver / drug effects
  • Liver / metabolism*
  • Membranes / chemistry
  • Membranes / metabolism
  • Mice
  • Mice, Knockout
  • Perfusion
  • Phospholipids / analysis
  • Phospholipids / metabolism
  • Sphingomyelins / analysis
  • Taurodeoxycholic Acid / pharmacology
  • Ursodeoxycholic Acid / pharmacology

Substances

  • ATP Binding Cassette Transporter, Subfamily B
  • Albumins
  • Carrier Proteins
  • Ceramides
  • Fluorescent Dyes
  • N-4-nitrobenzo-2-oxa-1,3-diazoleaminocaproyl sphingosylphosphorylcholine
  • Phospholipids
  • Sphingomyelins
  • Taurodeoxycholic Acid
  • Ursodeoxycholic Acid
  • N-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine
  • 4-Chloro-7-nitrobenzofurazan